News of the death comes less than a month after the FDA told physicians not to use the simulated intravenous products.
from @ Health and Medical News http://ift.tt/1523ER5
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
